摘要
目的 :探讨不同抗生素治疗呼吸道支原体感染的经济效果。方法 :抽取本院 10 7例呼吸道支原体感染患者 ,随机分为两组 ,根据不同治疗方案 (A组 :甲红霉素组 ;B组 :红霉素组 )运用药物经济学成本—效果分析方法进行评价。结果 :A组和B组方案总成本分别为 130 7 32元和 130 2 91元 ,其有效率分别为 90 91%和71 15 % ,每增加一个单位效果 ,A组仅较B组多花 0 2 2元。结论
Objective:To evaluate the economic efficiency of different antimicrobials in treatment of respiratory tract mycoplamal infections.Methods:107 cases of respiratory tract mycoplamal infections collected from this hospital were divided into two troups:A,clarithromycin;B,Erythromycin.Evaluation was carried out with pharmacoeconomic cost effectiveness analysis.Results:The total costs were 1307 32 yuans and 1302 91 yuans and the effective rates were 90 91% and 71 15% in groud A and B respectively.An increase of 1% effective rate in groud A only exspent 0 22 yuans in comparison with that in groud B.Conclusion:According to the evaluation with pharmacoecnomic cost effectiveness analysis,A is the best scheme.
出处
《武警医学院学报》
CAS
2003年第3期199-200,共2页
Acta Academiae Medicinae CPAPF
关键词
呼吸道支原体感染
甲红霉素
红霉素
成本—效果分析
Respiratory tract mycoplamal infections
Clarithromycin
Erythromycin
Cost effectiveness
